Target screening and optimization of candidate compounds for breast cancer treatment using bioinformatics and computational chemistry approaches

This study advances the understanding of molecular interactions in breast cancer therapy and demonstrates the potential of Molecule 10 as a highly effective therapeutic candidate. Integrating reverse drug screening, molecular modelling, and <i>in vitro</i> validation provides a robust platform for future drug discovery in breast cancer treatment.